Jim Heller Discusses Risperdal Trials in Law360

Tuesday, May 26, 2015

Jim Heller, chair of Cozen O'Connor's Products Liability Practice Group, discusses arguing to the jury whether Risperdal caused any of plaintiffs' injuries or damage rather than arguing their warning labels were sufficient. "It's a much more jury-friendly issue, I would say, because if they have evidence to show that these issues are related to things like weight gain and puberty, then the jury can understand that," Jim said. "It's something the jury can grasp rather than trying to decide through expert testimony what the company stated in its warnings, what the doctor knew about the risks and what the doctor said to the family."

To read the article, click here.


James H. Heller

Co-Chair, Commercial Litigation Department
Chair, Product Liability


(215) 665-2189


Related Practice Areas

Keep up-to-date with the latest news from Cozen O'Connor

Enter your City or Zip.

Probably shouldn't change this:
Sign up to receive alerts, publications, and event / webinar invites.

By submitting your contact information, you are giving Cozen O'Connor consent to contact you via email.